Insider Transactions in Q4 2021 at Acceleron Pharma Inc (XLRN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2021
|
Habib J Dable CEO and President |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
98,450
-100.0%
|
-
|
|
Nov 19
2021
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
10,681
-100.0%
|
-
|
|
Nov 19
2021
|
Jay T. Backstrom EVP, Research and Development |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
21,233
-100.0%
|
-
|
|
Nov 19
2021
|
Sujay Kango EVP, Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
18,509
-100.0%
|
-
|
|
Nov 19
2021
|
Adam M Veness SVP, General Counsel and Sec. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
23,423
-100.0%
|
-
|
|
Nov 19
2021
|
Francois Nader Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,749
-100.0%
|
-
|
|
Nov 19
2021
|
Laura Hamill Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
474
-100.0%
|
-
|
|
Nov 19
2021
|
Terrence C Kearney Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,749
-100.0%
|
-
|
|
Nov 19
2021
|
Thomas A Mccourt Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,044
-100.0%
|
-
|
|
Nov 19
2021
|
Karen L. Smith Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,622
-100.0%
|
-
|
|
Nov 19
2021
|
Christopher Hite Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
930
-100.0%
|
-
|
|
Nov 19
2021
|
Kemal Malik Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,622
-100.0%
|
-
|
|
Nov 19
2021
|
Joseph S Zakrzewski Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
34,499
-100.0%
|
-
|
|
Nov 09
2021
|
Adam M Veness SVP, General Counsel and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+16.12%
|
$130,500
$29.37 P/Share
|